Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 19/20 | 0.73 |
| ▸ | NUDT14 | O95848 | 2/20 | 0.73 |
| ▸ | NUDT5 | Q9UKK9 | 2/20 | 0.73 |
| ▸ | LCK | P06239 | 3/20 | 0.66 |
| ▸ | SRC | P12931 | 1/20 | 0.66 |
| ▸ | KDR | P35968 | 1/20 | 0.66 |
| ▸ | TEK | Q02763 | 1/20 | 0.66 |
| ▸ | LYN | P07948 | 1/20 | 0.64 |
| ▸ | EGFR | P00533 | 2/20 | 0.57 |
| ▸ | ITK | Q08881 | 1/20 | 0.57 |
| ▸ | TEC | P42680 | 1/20 | 0.57 |
| ▸ | TXK | P42681 | 1/20 | 0.57 |
| ▸ | BMX | P51813 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22737367 | 1.00 | BTK (0.73) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22737365 | 1.00 | BTK (0.73) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22737557 | 1.00 | BTK (0.73) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL24197163 | 1.00 | BTK (0.73) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22737590 | 0.91 | BTK (0.68) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22738101 | 0.89 | BTK (0.64) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22737315 | 0.89 | BTK (0.64) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22737833 | 0.89 | BTK (0.64) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL22737838 | 0.89 | BTK (0.64) | BTKNUDT14NUDT5LCKSRC | |
| SCHEMBL24827903 | 0.89 | BTK (0.62) | BTKNUDT14NUDT5LCKSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4180432-A1 | COMPOUND HAVING BTK KINASE DEGRADING ACTIVITY, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR | Sichuan Haisco Pharmaceutical Co., Ltd. (CN) | 2023-05-17 | — | — | EP | disclosed |
| WO-2022007824-A1 | COMPOUND HAVING BTK KINASE DEGRADING ACTIVITY, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR | 四川海思科制药有限公司 | 2022-01-13 | — | — | WO | disclosed |